Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
EVH · against 448 other Healthcare companies of similar size
Ranked #289 of 449 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score161 peers with a valuation score of 0–9, including EVH · Click a bar to see the companies
Mainly because of its earnings yield, which is weaker than most Healthcare peers.
| Metric | EVH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 436 reported | -104.4% | 0.5% | 1% | 30% | |
| EBITDA yieldHigher is better · 454 reported | 4.6% | 3.3% | 55% | 50% | |
| Free cash flow yieldHigher is better · 204 reported | 5.0% | -6.7% | 82% | 20% | |
| Book yieldHigher is better · 446 reported | 79.1% | 48.6% | 75% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 289 | 302M USD | 8 | 17 | |
| 289 | 530M USD | 8 | 23 | |
| 289 | 487M USD | 8 | 29 | |
| 289 | 455M USD | 8 | 36 | |
| 289 | 486M USD | 8 | 16 | |
| 289 | 551M USD | 8 | 27 | |
| 289 | 508M EUR (≈$559M) | 8 | 21 | |
| 289 | 660M USD | 8 | 43 | |
| 289 | 375M USD | 8 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score